• Unaudited revenue of $1.05m in Q1 FY26, a 46% increase on prior quarter
• Strong sales into Australian wholesale channels and recognition of Zildjian product shipment
• Additional value accretive opportunities pending across international markets

Audeara Limited (ASX: AUA), a leading provider of advanced hearing health technology, has provided a trading update for Q1 FY26, highlighting strong revenue momentum. The company reported unaudited revenue of $1.05m for the quarter, marking a 46% increase on the prior quarter's unaudited revenue of $0.72m. This growth is underpinned by strong sales into Australian wholesale channels, which continue to grow on a quarter-by-quarter basis, as well as the receipt of payment from Avedis Zildjian for deliveries in connection with a follow-up purchase order through the Company's AUA Technology division. The strong revenue momentum follows Audeara's recent agreement with Eastech (Huizhou) Co., Ltd., a wholly owned subsidiary of Eastech Holding Limited (TWSE: 5225), to support the entry of Audeara's proprietary hearing technology into the Chinese medical device market. This partnership has the potential to deliver further sales growth during H2 CY25. In addition to the Chinese market opportunity, Audeara sees additional value accretive opportunities pending across other international markets, complemented by ongoing sales through Australian wholesale groups, retail sales and channels, and key resellers, as well as ongoing collaborations with international counterparties and the AUA Technology division.

The company anticipates additional growth to be demonstrated through ongoing international expansion opportunities and hardware sales.